LEONARDI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 6.320
EU - Europa 625
AS - Asia 294
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
AF - Africa 2
OC - Oceania 2
Totale 7.250
Nazione #
US - Stati Uniti d'America 6.313
CN - Cina 266
FI - Finlandia 140
DE - Germania 125
IT - Italia 123
UA - Ucraina 76
GB - Regno Unito 69
SE - Svezia 57
VN - Vietnam 16
NL - Olanda 12
IE - Irlanda 8
IN - India 6
RU - Federazione Russa 6
EU - Europa 4
MX - Messico 4
BR - Brasile 3
CA - Canada 3
FR - Francia 3
AU - Australia 2
BW - Botswana 1
HK - Hong Kong 1
HU - Ungheria 1
IR - Iran 1
KZ - Kazakistan 1
LT - Lituania 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 7.250
Città #
Fairfield 1.114
Woodbridge 701
Houston 528
Chandler 502
Ashburn 433
Ann Arbor 406
Cambridge 398
Seattle 390
Jacksonville 389
Wilmington 379
Princeton 180
San Diego 115
Roxbury 90
Beijing 73
Medford 72
Des Moines 58
Helsinki 57
Nanjing 56
Padova 52
Boardman 43
Nanchang 22
New York 18
Dong Ket 16
Shenyang 16
Hebei 15
Tianjin 14
Guangzhou 13
London 13
Jiaxing 11
Jinan 11
Grafing 9
Dublin 8
Redwood City 8
Kilburn 7
Milan 7
Ogden 7
Zhengzhou 7
Norwalk 6
Changsha 5
Falls Church 5
Hounslow 5
Tappahannock 5
Verona 5
Munich 4
Nürnberg 4
Vicenza 4
Brunssum 3
Haikou 3
Kharkiv 3
Los Angeles 3
Naples 3
Ningbo 3
Pune 3
Shanghai 3
Acton 2
Alghero 2
Bari 2
Campolongo Maggiore 2
Coral Gables 2
Fontanelle 2
Fuzhou 2
Hangzhou 2
Hermosillo 2
Indiana 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Las Vegas 2
Palermo 2
Redmond 2
Rome 2
San Donà di Piave 2
San Francisco 2
São Paulo 2
Yellow Springs 2
Almaty 1
Aprilia 1
Atlanta 1
Birmingham 1
Bologna 1
Borås 1
Bratislava 1
Brendola 1
Brisbane 1
Budapest 1
Carpineti 1
Cerro Maggiore 1
Chennai 1
Chiampo 1
Chiswick 1
Ciserano 1
Clearwater 1
Como 1
Costa Mesa 1
Dallas 1
Delhi 1
Falkenstein 1
Frankfurt am Main 1
Gaborone 1
Groningen 1
Totale 6.372
Nome #
Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma 141
Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type, and are modified by inflammatory stimuli 132
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression 121
Tear histamine and histaminase during the early (EPR) and late (LPR) phases of the allergic reaction and the effects of Lodoxamide. 112
Efficacy and Tolerability of Ketotifen in the Treatment Of Seasonal Allergic Conjunctivitis: Comparison between Ketotifen 0.025% and 0.05% Eye Drops 109
Vernal keratoconjunctivitis-like disease in adults 108
Urokinase Plasminogen Activator, uPa Receptor, and Its Inhibitor in Vernal Keratoconjunctivitis 107
Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities 106
Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis. 106
A novel plasma source for sterilization of living tissues 105
A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study 105
Unusual high exposure to ultraviolet-C radiation 104
Th1- and Th2-type cytokines in chronic ocular allergy 104
Urban eye allergy syndrome: a new clinical entity? 99
Microarray-based IgE detection in tears of patients with vernal keratoconjunctivitis 99
Profile of Lipid and Protein Autacoids in Diabetic Vitreous Correlates With the Progression of Diabetic Retinopathy 98
Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans 96
Using helium-generated cold plasma to control infection and healing 96
Corneal staining patterns in vernal keratoconjunctivitis: The new VKC-CLEK scoring scale 94
Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. 92
Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis 91
Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. 91
Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis. 91
Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. 90
Characterisation of the phenotype and function of monocyte-derived dendritic cells in allergic conjunctiva 88
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: A pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies 87
Is visual function affected in severe ocular allergies? 86
Managing ocular allergy in the time of COVID-19 85
Tailored Approach to the Treatment of Vernal Keratoconjunctivitis 83
Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy 83
Tear eosinophil cationic protein (ECP) in tears of normal subjects and patients affected by vernal keratoconjunctivitis. 82
Emerging drugs for ocular allergy 82
Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma 80
Atmospheric-pressure cold plasma induces transcriptional changes in ex vivo human corneas 80
Histaminase activity in vernal keratoconjunctivitis. 79
Prevalence of vernal keratoconjunctivitis: a rare disease? 79
Olopatadine: a drug for allergic conjunctivitis targeting the mast cell 78
Allergic conjunctivitis: A cross-sectional study 78
Effect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitro 77
Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis. 77
Allergy and allergic mediators in tears 77
Cytokines, growth factors and MMPs in tears of vernal keratoconjunctivitis (VKC) patients 77
Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. 76
Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis 74
Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population. 74
Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis 73
Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases 72
Corneal confocal microscopy in patients with vernal keratoconjunctivitis 71
Effects of cyclosporin A on human conjunctival fibroblasts 71
Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model 70
Detection of severe acute respiratory syndrome coronavirus 2 in corneas from asymptomatic donors 70
Conjunctival allergen provocation test : guidelines for daily practice 68
Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. 66
Vernal keratoconjunctivitis: pathogenesis and treatment 65
Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis 64
Vernal keratoconjunctivitis: A severe allergic eye disease with remodeling changes 64
Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score 64
Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics 63
Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis 63
Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. 62
Effects of Th2 cytochines on expression of collagen, MMP-1 and TIMP-1 in conjunctival fibroblasts 62
Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments 59
Ocular Surface Expression of SARS-CoV-2 Receptors 59
Cytokine and chemochine levels in tears and in corneal fibroblast cultures before and after excimer laser treatment 57
Towards a plasma treatment of corneal infections 57
Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study 56
Small fiber peripheral neuropathy in Wilson disease: an in vivo documentation by corneal confocal microscopy. 56
Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. 55
Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in keratoconjunctivitis patients 55
The regulatory activity of autophagy in conjunctival fibroblasts and its possible role in vernal keratoconjunctivitis 54
Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis 54
Office-based ocular procedures for the allergist 52
Epidemiology of allergic conjunctivitis: Clinical appearance and treatment patterns in a population-based study 51
In-vivo diagnostic measurements of ocular inflammation 50
Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease 50
Clinical patterns of ocular anaphylaxis in guinea pigs passively sensitized with IgG1 antibodies. 46
Investigation of the effects of atmospheric pressure cold plasma 45
Efficacy and comfort of olopatadine vs ketotifen ophthalmic solutions 44
Nonsteroidal antiinflammatory drugs after excimer laser photorefractive keratectomy (PRK): A randomized double blind study 44
Growth factors and collagen distribution in vernal keratoconjunctivitis 43
Trypsin inhibitory capacity in vernal keratoconjunctivitis 42
Eosinophils and CD4+ cells contribute to MMP production and tissue remodeling in veronal keratoconjunctivitis and other allergic diseases 41
Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis 40
Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine 40
Differential expression of matrix metalloproteinases in vernal keratoconjunctivitis, allergic asthma and nasal polyps 39
In vitro effects of fluorochinolone and aminoglycoside antibiotics on human keratocytes 38
Low temperature plasma device for the treatment of corneal infections 38
Ocular Surface Expression of SARS-CoV-2 Receptors 38
Management of ocular allergy 37
Two years specific sublingual immunotherapy with alternaria extracts 36
Effects of cold plasma on pathogenic microorganisms, cells and corneal tissues. 36
Characterization of dendritic cell phenotype in allergic conjunctiva: increased expression of Fc epsilon RI, the high-affinity receptor for immunoglobulin E 35
Heat shock proteins levels and expression in chronic obstructive pulmonary disease and vernal keratoconjunctivitis 34
Management of Vernal Keratoconjunctivitis 31
Matrix metalloproteinases in vernal keratoconjunctivitis, nasal polyps and allergic asthma. 29
Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. 29
Diagnostic tools in ocular allergy 29
Urokinase and plasminogen activation in vernal keratoconjunctivitis patients 28
Metagenomic analysis of the conjunctival bacterial and fungal microbiome in vernal keratoconjunctivitis 28
Tear N-glycomics in vernal and atopic keratoconjunctivitis 27
Totale 6.929
Categoria #
all - tutte 27.726
article - articoli 26.952
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 100
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.778


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019495 0 0 0 0 0 0 0 0 0 0 274 221
2019/20201.440 224 52 36 90 149 119 129 178 154 155 89 65
2020/20211.414 54 73 29 104 46 112 205 151 253 153 155 79
2021/20221.507 35 165 185 88 72 63 116 160 90 29 161 343
2022/20231.006 249 89 60 100 169 96 1 65 104 9 49 15
2023/2024330 19 71 52 42 23 34 16 18 45 10 0 0
Totale 7.360